|
PKP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49729999998627E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.92259999931954E-08 |
| Normal-vs-Stage2 |
4.91930000001695E-06 |
| Normal-vs-Stage3 |
1.439560E-03 |
| Normal-vs-Stage4 |
5.405200E-01 |
| Stage1-vs-Stage2 |
7.752200E-01 |
| Stage1-vs-Stage3 |
2.134800E-01 |
| Stage1-vs-Stage4 |
4.215000E-01 |
| Stage2-vs-Stage3 |
2.284000E-01 |
| Stage2-vs-Stage4 |
3.815800E-01 |
| Stage3-vs-Stage4 |
6.461000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.65159999957021E-07 |
| Normal-vs-AfricanAmerican |
3.242100E-04 |
| Normal-vs-Asian |
4.139100E-03 |
| Caucasian-vs-AfricanAmerican |
5.273200E-01 |
| Caucasian-vs-Asian |
7.034800E-01 |
| AfricanAmerican-vs-Asian |
6.226000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.16889999480475E-08 |
| Normal-vs-Female |
4.955400E-04 |
| Male-vs-Female |
1.232790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.71668999999763E-05 |
| Normal-vs-Extreme_Weight |
4.45800000248298E-08 |
| Normal-vs-Obese |
4.697400E-03 |
| Normal-vs-Extreme_Obese |
1.430180E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.600400E-01 |
| Normal_Weight-vs-Obese |
7.065800E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.197600E-01 |
| Extreme_Weight-vs-Obese |
2.840200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.392000E-01 |
| Obese-vs-Extreme_Obese |
1.773770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.405800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.361100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.37020411578237E-11 |
| Normal-vs-Age(81-100Yrs) |
2.575300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.432600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.751770E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.706300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.444820E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.156600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.736600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.59240000261607E-08 |
| Normal-VS-Type2 PRCC |
4.55629999951412E-07 |
| Normal-VS-KIRP CIMP |
9.580800E-01 |
| Normal-VS-Unclassified PRCC |
2.941700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.166000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.622620E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.996800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.495200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.479800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.015200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.7328000024317E-08 |
| Normal-vs-N1 |
6.097400E-01 |
| Normal-vs-N2 |
1.968180E-01 |
| N0-vs-N1 |
2.240200E-02 |
| N0-vs-N2 |
2.296000E-01 |
| N1-vs-N2 |
6.810800E-01 |
|
|
